tldrdaily.news logo
Tag

Glp 1 Drugs

All articles tagged with #glp 1 drugs

Obesity Persists in the U.S. While GLP-1 Weight-Loss Drugs Surge
medicine-and-health1 month ago

Obesity Persists in the U.S. While GLP-1 Weight-Loss Drugs Surge

A Pew Research Center analysis of 2024–2025 data finds about 40% of U.S. adults are obese (around 10% severely obese) with a slight decline since 2017–18; 65% say willpower alone isn’t enough to lose weight. Roughly half of Americans report hearing about Ozempic, Wegovy, and similar GLP-1 drugs extremely or very often, with women and older adults more likely to say so. Public opinion skews toward using GLP-1s for obesity-related health conditions rather than for weight loss alone. GLP-1 drugs have generated billions in revenue—Novo Nordisk’s 2024 GLP-1 sales totaled about $31.1 billion (majority from the U.S.), and Lilly’s Mounjaro/Zepbound have also surged. Medicaid coverage varies by state (13 cover GLP-1s for obesity, 7 cover some weight-loss drugs but not GLP-1s), and prescriptions rose from about 1.3 million in 2019 to 8.4 million in 2024, with spending climbing to roughly $8.6 billion.

via Pew Research Center|
#glp-1-drugs#medicaid-coverage#medicine-and-health
Real-world GLP-1 weight loss often endures after stopping therapy
health1 month ago

Real-world GLP-1 weight loss often endures after stopping therapy

A real-world analysis of 135,000+ patients on GLP-1 therapies (tirzepatide and semaglutide) found weight loss durability after discontinuation. Six months after stopping, about 28% of tirzepatide users regained weight, while 36% kept it off and 36% continued to lose; for semaglutide, ~33% regained, ~32% maintained, and ~35% still lost weight, with a median six‑month change of 0%. The findings suggest durability is possible in routine care and could support a disease-management approach, especially when paired with exercise counseling. Limitations include its observational nature and incomplete accounting for dose and lifestyle factors; results differ from some clinical trial findings and more research is needed to identify who maintains weight loss long-term.

via Reuters|
#drug-discontinuation#glp-1-drugs#health
Novo Nordisk's GLP-1 Weight-Loss Pills Spark Price Competition
business1 month ago

Novo Nordisk's GLP-1 Weight-Loss Pills Spark Price Competition

Novo Nordisk has announced a price reduction for its Wegovy weight-loss pill in the US to compete with Eli Lilly's market offerings, initiating a price war in the weight-loss drug industry. The company will offer lower doses at significantly reduced prices, aiming to attract more overweight and obese patients, especially following the recent FDA approval of an oral version of Wegovy. This move comes amid a competitive landscape with Lilly's upcoming drug, orforglipron, expected to be approved soon.

via Financial Times|
#business#glp-1-drugs#novo-nordisk
Top 3 Discounted Drug Stocks to Watch
business2 months ago

Top 3 Discounted Drug Stocks to Watch

The article discusses the recent developments in the GLP-1 drug market, highlighting Novo Nordisk's new pill and the potential of out-of-favor drug makers like Bristol Myers Squibb, Merck, and Pfizer as long-term investment opportunities due to their efforts to innovate and survive patent cliffs. Despite current setbacks, these companies are positioned for future growth, making them attractive for contrarian investors.

via The Motley Fool|
#business#glp-1-drugs#merck
Ozempic Users Experience Muscle Loss Concerns
health2 months ago

Ozempic Users Experience Muscle Loss Concerns

People taking GLP-1 drugs like Ozempic for weight loss are experiencing significant muscle loss and weakness, raising concerns about the reliance on these medications as shortcuts without proper diet and exercise. Experts emphasize the importance of combining these drugs with protein-rich diets and strength training to prevent adverse effects and promote healthier weight management.

via vox.com|
#glp-1-drugs#health#muscle-loss
Australia Issues New Mental Health Warnings for Ozempic and Similar Weight-Loss Drugs
health2 months ago

Australia Issues New Mental Health Warnings for Ozempic and Similar Weight-Loss Drugs

Health authorities warn about increased risks of suicidal thoughts and potential contraception failures associated with GLP-1 drugs like Ozempic and Mounjaro, which are used for diabetes and weight loss. While these drugs are generally effective, they may impact hormone absorption, reducing contraceptive efficacy, especially oral contraceptives. Patients should consult their doctors if experiencing mood changes or suicidal thoughts and consider alternative contraception methods if on GLP-1 medications. Use during pregnancy is not recommended due to potential risks.

via ScienceAlert|
#contraception#glp-1-drugs#health
Brooks Nader Opens Up About Cosmetic Procedures and Weight-Loss Drugs
entertainment3 months ago

Brooks Nader Opens Up About Cosmetic Procedures and Weight-Loss Drugs

Brooks Nader openly discusses her extensive cosmetic procedures, including injectables, a nose job, veneers, and her use of GLP-1 drugs to lose weight, which she credits for boosting her modeling career. She joins other celebrities like Simone Biles and Khloe Kardashian in sharing their cosmetic enhancements, highlighting a trend of transparency in the industry.

via Page Six|
#brooks-nader#cosmetic-procedures#entertainment